Trial intelligence / Profile preview

Adjunctive Minocycline for Treatment-Resistant Unipolar Major Depressive Disorder

DRKS00009444Phase 2Completed

Sponsor
Charité - Universitätsmedizin Berlin, Sponsorvertretung: Frau Prof. Dr. Dipl.-Psych. Isabella Heuser Charitéplatz 1
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Minocycline + standard antidepressant treatment with Placebo + standard antidepressant treatment (2 arms). Started Dec 2015; status: completed.

02

Drugs

minocycline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on DRKS00009444.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00009444.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call